(Q27130158)

GalNAc-alpha1,4GlcNAc (English)

6 October 2016

chemical formula

C₁₆H₂₈N₂O₁₁

1 reference

GalNAc-alpha1,4GlcNAc (English)

6 October 2016

canonical SMILES

CC(=O)NC1C(C(C(OC1O)CO)OC2C(C(C(C(O2)CO)O)O)NC(=O)C)O

1 reference

GalNAc-alpha1,4GlcNAc (English)

6 October 2016

isomeric SMILES

CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@@H]1O[C@@H]2[C@H](OC([C@@H]([C@H]2O)NC(=O)C)O)CO)CO)O)O

1 reference

GalNAc-alpha1,4GlcNAc (English)

InChI=1S/C16H28N2O11/c1-5(21)17-9-13(25)14(8(4-20)27-15(9)26)29-16-10(18-6(2)22)12(24)11(23)7(3-19)28-16/h7-16,19-20,23-26H,3-4H2,1-2H3,(H,17,21)(H,18,22)/t7-,8-,9-,10-,11+,12-,13-,14-,15?,16-/m1/s1

6 October 2016

Identifiers

InChI

1 reference

GalNAc-alpha1,4GlcNAc (English)

CDOJPCSDOXYJJF-BHKGJTDZSA-N

6 October 2016

InChIKey

2 references

GalNAc-alpha1,4GlcNAc (English)

6 October 2016

stated in

ChEBI release 2020-09-01

1 reference

2-Acetamido-4-O-(2-acetamido-2-deoxy-alpha-D-galactopyranosyl)-2-deoxy-D-glucopyranose (English)

6 October 2016

1 reference

GalNAc-alpha1,4GlcNAc (English)

6 October 2016

ChEBI ID

60945

mapping relation type

1 reference

Immune Epitope Database and Analysis Resource

alpha-D-GalpNAc-(1->4)-D-GlcpNAc (English)

6 October 2016

1 reference

1 reference

IEDB Epitope ID

152216